3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
NETWORK
1
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Gastrointestinal
1
Conditions
Leukemia, Myeloid, Acute
3
Breast Neoplasms
3
Prostatic Neoplasms
2
Neuroblastoma
2
Leukemia, Myelomonocytic, Acute
2
Leukemia, Monocytic, Acute
2
Leukemia, Megakaryoblastic, Acute
2
Leukemia, Erythroblastic, Acute
2
Leukemia
2
Endometrial Neoplasms
2
Congenital Abnormalities
2
Stage I Mixed Cell Type Kidney Wilms Tumor
1
Squamous Intraepithelial Lesions
1
Squamous Cell Carcinoma of Head and Neck
1
Sarcoma, Synovial
1
Sarcoma, Alveolar Soft Part
1
Sarcoma
1
Pleuropulmonary blastoma
1
Papillomavirus Infections
1
Pain
1
Neurofibrosarcoma
1
Neoplasms
1
Myeloproliferative Syndrome, Transient
1
Meningioma
1
Melanoma
1
Malignant mesenchymal tumor
1
Lymphoma, Large B-Cell, Diffuse
1
Lung Neoplasms
1
Liposarcoma
1
Leukemia, Eosinophilic, Acute
1
Interventions
Radiotherapy, Intensity-Modulated
3
Polymerase Chain Reaction
3
Cisplatin
3
Watchful Waiting
2
Light Coagulation
2
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
2
Cetuximab
2
Restraint, Physical
1
Platinum
1
Paclitaxel
1
Observation
1
Laser Therapy
1
Independent Medical Evaluation
1
Imiquimod
1
Histological Techniques
1
Fluorouracil
1
Flow Cytometry
1
Carboplatin
1
Biopsy
1
Albumin-Bound Paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
NETWORK
×
Papillomavirus Infections
×
Observation
×
Clear all
NCT02135419
2024-07-26
ANCHOR
AIDS Malignancy Consortium
Phase 3
Completed
4,446 enrolled
13 charts